Boston Scientific: EVP Jeffrey Mirviss to retire as Peripheral Interventions head Dec. 1, 2025
Boston Scientific said Executive Vice President and President of Peripheral Interventions Jeffrey B. Mirviss will retire from that role effective December 1, 2025, and will then serve as a senior advisor through February 27, 2026. The company expects to sign a retirement agreement with him with payments and benefits materially consistent with existing plans, which matters to shareholders mainly as a routine leadership transition in one business unit.
Key points
- Mirviss informed the company of his retirement decision on August 29, 2025.
- Retirement from his executive role takes effect December 1, 2025.
- He will stay on as a senior advisor until the Retirement Date, no later than February 27, 2026, at his current $705,000 annual base salary, prorated.
- A Retirement Agreement is expected, with terms materially consistent with existing executive retirement, bonus and long-term incentive plans.
The filing
Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 04, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.